Ameriprise’s Transphorm, Inc. Common Stock TGAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,722,304
| Closed | -$23.2M | – | 3967 |
|
|
2024
Q1 | $23.2M | Sell |
4,722,304
-221,508
| -4% | -$1.05M | 0.01% | 1218 |
|
|
2023
Q4 | $18M | Buy |
4,943,812
+500,483
| +11% | +$1.37M | 0.01% | 1339 |
|
|
2023
Q3 | $9.86M | Buy |
4,443,329
+379,560
| +9% | +$1.06M | ﹤0.01% | 1714 |
|
|
2023
Q2 | $13.8M | Buy |
4,063,769
+134,721
| +3% | +$486K | ﹤0.01% | 1517 |
|
|
2023
Q1 | $15.7M | Buy |
3,929,048
+123,500
| +3% | +$544K | 0.01% | 1437 |
|
|
2022
Q4 | $20.7M | Sell |
3,805,548
-47
| -0% | -$277 | 0.01% | 1209 |
|
|
2022
Q3 | $19.1M | Buy |
3,805,595
+34,328
| +0.9% | +$169K | 0.01% | 1206 |
|
|
2022
Q2 | $14.4M | Buy |
3,771,267
+168,786
| +5% | +$1.08M | 0.01% | 1454 |
|
|
2022
Q1 | $25.5M | Buy |
+3,602,481
| New | +$25.3M | 0.01% | 1173 |
|